Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity

Abstract

References

The separation of total plasma insulin from binding proteins using gel filtration: its application to the measurement of rate of insulin disappearance

Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients

Serum insulin in remission of juvenile diabetes

Remission of juvenile diabetes

"Big insulin": a new component of plasma insulin detected by immunoassay

Identification of proinsulin and C-peptide in human serum by a specific immunoassay

Properties of proinsulin and related polypeptides

Glucose-stimulated insulin secretion during "remission" of juvenile diabetes

Diabetic ketoacidosis: evidence for C-peptide and proinsulin secretion following recovery

Effect of control of hyperglycemia on plasma insulin responses to various stimuli in newly diagnosed ketosis-prone diabetic patients

Juvenile diabetes mellitus

Clinical remission in diabetes mellitus. Studies of insulin secretion

Juvenile diabetes mellitus, a deficiency in insulin

Improvement in both insulin sensitivity and release following diabetic coma

Electrophoretic characterization of circulating human proinsulin and insulin

Studies of diabetic instability. I. Immunoassay of human insulin in plasma containing antibodies to pork and beef insulin

Coated charcoal immunoassay of insulin

Determination of free and antibody-bound insulin in insulin treated diabetic patients

Human serum proinsulin

Endogenous insulin and growth hormone response in children with newly diagnosed diabetes mellitus

Plasma insulin during remission in juvenile diabetes mellitus

The early partial remission of juvenile diabetes mellitus. The roles of insulin and growth hormone

Insulin-resistant diabetes associated with increased endogenous plasma insulin followed by complete remission

Quantitative aspects of the reaction between insulin and insulin-binding antibody

PRODUCTION OF AUTOANTIBODIES TO INSULIN IN MAN AND RABBITS

The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma

Citations

The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients

C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide

Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children

Loss of regular oscillatory insulin secretion in islet cell antibody positive non-diabetic subjects

Human C-peptide in normal and diabetic subjects

Human C-peptide immunoreactivity (CPR) in blood and urine - evaluation of a radioimmunoassay method and its clinical applications

B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment

Serum insulin, insulin antibodies and insulin requirement in the first period of insulin treatment in non-insulin resistant diabetics

Pancreatic B-cell response to a test-meal in lean and obese diabetic patients: relation to metabolic control

Duration of residual B-cell function in maturity-onset diabetes

C-peptide response to arginine stimulation in diabetic children

Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies

Insulin-dependent diabetes mellitus: the initial lesion

Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity

Juvenile diabetes mellitus: possibility of prevention

Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus

Introduction of Arthur H. Rubenstein

Circulating serum C-peptide. A brief review of diagnostic implications

Distinct roles of β-cell mass and function during type 1 diabetes onset and remission

Size-controlled insulin-secreting cell clusters

Management of childhood diabetes

C-peptide in the natural history of type 1 diabetes

C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus

Proinsulin and C-peptide: a review

Changes in endogenous insulin secretion during childhood as expressed by plasma and urinary C-peptide

Reversal of insulin resistance in type 1 diabetes following initiation of insulin treatment

Islet morphologic changes

Type 2 diabetes in Arab patients in Kuwait

Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity

Diagnosis of pancreatic islet hyperplasia causing hypoglycemia in a patient with portacaval anastomosis

Combination immunotherapies for type 1 diabetes mellitus

The pancreatic islets in diabetes

Early phase of juvenile IDDM--environmental and genetic intervention

C-peptide measurement: methods and clinical utility

Multivariate analysis of glycosylated haemoglobin in insulin-treated diabetics

Factors of importance for residual beta-cell function in type I diabetes mellitus. A review

Des-(27-31)C-peptide. A novel secretory product of the rat pancreatic beta cell produced by truncation of proinsulin connecting peptide in secretory granules

Type I diabetes. Control with individualized insulin regimens

Human C-peptide. Part II: Clinical studies

Childhood diabetes. Family-oriented approach to management

Can the Molar Insulin: C-Peptide Ratio Be Used to Predict Hyperinsulinaemia?

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Related Papers

Diabetic ketoacidosis: evidence for C-peptide and proinsulin secretion following recovery

Human C-peptide in normal and diabetic subjects

Correspondence: Down's syndrome with diabetes mellitus and hypothyroidism

Plasma C-peptide and diagnosis of factitious hyperinsulinism. Study of an insulin-dependent diabetic patient with "spontaneous" hypoglycemia